Offerings // Genenta Science S.p.A.

GNTA offering history

Every offering-related filing in Genenta Science S.p.A.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 119 filings back to Mar 1, 2021.

Last executed offering
Jan 27, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
May 12, 2023
F-3 — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Jan 27, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 28, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 28, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 20, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 26, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 24, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 12, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Dec 15, 2021424B1 →EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Dec 15, 2021424B1 →EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Dec 14, 2021F-1MEF →REGISTEREDF-1MEF registration — capacity to sell shares, not a sale yet
Dec 14, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 7, 2021F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 24, 2021F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 9, 2021F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
GNTA offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full GNTA workspace →
GNTA offering FAQ

When did GNTA last execute an offering?

Per SEC filings, Genenta Science S.p.A.'s most recent priced offering document is a 424B5 filed 2026-01-27. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did GNTA last announce or register an offering?

The most recent registration is a F-3 filed 2023-05-12. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.